Home
Chemicals

Sector: Chemicals

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

Nanoco eyeing further assertions following big-money Samsung pay-out, says CEO

Brian Tenner sits down with IAM to discuss the company’s win and future strategy

The fast-evolving cannabis patent dispute landscape

GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation

Latest content

Everything you need to know about SCOTUS’ Minerva ruling on assignor estoppel

In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.

01 July 2021

Another startup taps Aon for insurance-backed IP financing

Insurance giant, which recently announced a $400m IP fund, says it has a strong pipeline of lending deals in the works

17 June 2021

Tesla transactions show that patents matter in research collaboration and M&A

Recent recordals show the electric car maker has cut a deal with Panasonic, assimilated a large portfolio of solar rights and gained assets via M&A deals

16 June 2021

Brazilian Supreme Court set to decide whether tens of thousands of patents live or die

Up to 30,000 individual grants are at risk as the country’s highest court decides whether to retroactively apply a landmark ruling it handed down last week

11 May 2021

Biden backs covid-19 IP waiver in historic US policy shift

Landmark move suggests realignment in America’s domestic and international healthcare IP stance

06 May 2021

Brazilian Senate passes compulsory covid-19 know-how licensing bill

Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress

04 May 2021

Hatch-Waxman litigation defendants get taxation boost

A ruling handed down by the US Tax Court this week suggests generics can deduct legal fees for ANDA litigation

29 April 2021

Why high-tech patent expertise will be increasingly valued by life sciences companies

If the experience of NantWorks’ IP chief Mark Kokes is anything to go by, leading strategists from other sectors can make a splash in pharma and biotech

24 April 2021

SCOTUS looks likely to limit the assignor estoppel doctrine

Yesterday’s hearing in Minerva Surgical v Hologic is likely to have big implications for transactions and assignee-assignor disputes

22 April 2021

Korean Supreme Court tears up tough inventiveness standard

Life sciences innovators set to benefit from landmark Eliquis decision

15 April 2021

Unlock unlimited access to all IAM content